Since the Fmr1 gene has been identified as an autism-related gene and the most common cause of autism [295], modulation of mGluRs for the treatment of FXS might also be beneficial for autism, which is also supported by the observation that MPEP blocked repetitive features in a mice model of autism [296]. This evidence concerns the gene FMR1 and fragile X syndrome.